Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
2 clinical trials · Condition
◉ Watch Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
| Record | Firm | Date |
|---|---|---|
| HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib (NCT03786107) | Puma Biotechnology, Inc. | 2019-03-14 |
Track Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.